Login
$ELVN
$47.62 -$1.18 (2.42%) Live

Insider Transactions

What Enliven Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 9 73
Total trades 16 102

Shares traded

3 months 12 months
Acquired 44,041 482,634
Disposed 35,036 1,784,759
Net activity +9,005 −1,302,125

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Kunkel Lori Anne Director Oct 30 Exercise / conversion · M +7,300 $18.30 +$134K 52,925
Kunkel Lori Anne Director Oct 30 Exercise / conversion · M +3,741 $1.12 +$4.19K 45,625
Collins Helen Louise CHIEF MEDICAL OFFICER Oct 19 Open-market sale · S −5,000 $38.47 −$192K 25,000
Collins Helen Louise CHIEF MEDICAL OFFICER Oct 19 Exercise / conversion · M +5,000 $2.48 +$12.4K 30,000
Hohl Benjamin CHIEF FINANCIAL OFFICER Oct 19 Open-market sale · S −6,018 $38.48 −$232K 38,000
Hohl Benjamin CHIEF FINANCIAL OFFICER Oct 19 Exercise / conversion · M +6,018 $14.85 +$89.4K 44,018
Garland J. Scott Director Oct 01 Open-market sale · S −13,000 $46.67 −$607K 0
Garland J. Scott Director Oct 01 Exercise / conversion · M +13,000 $15.47 +$201K 13,000
Hohl Benjamin CHIEF FINANCIAL OFFICER Sep 17 Open-market sale · S −289 $51.49 −$14.9K 38,000
Hohl Benjamin CHIEF FINANCIAL OFFICER Sep 17 Open-market sale · S −2,194 $50.72 −$111K 38,289
Hohl Benjamin CHIEF FINANCIAL OFFICER Sep 17 Open-market sale · S −3,535 $50.03 −$177K 40,483
Hohl Benjamin CHIEF FINANCIAL OFFICER Sep 17 Exercise / conversion · M +3,982 $14.85 +$59.1K 44,018
Collins Helen Louise CHIEF MEDICAL OFFICER Sep 17 Open-market sale · S −240 $51.48 −$12.4K 25,000
Collins Helen Louise CHIEF MEDICAL OFFICER Sep 17 Open-market sale · S −1,844 $50.71 −$93.5K 25,240
Collins Helen Louise CHIEF MEDICAL OFFICER Sep 17 Open-market sale · S −2,916 $50.03 −$146K 27,084
Collins Helen Louise CHIEF MEDICAL OFFICER Sep 17 Exercise / conversion · M +5,000 $2.48 +$12.4K 30,000
Collins Helen Louise CHIEF MEDICAL OFFICER Aug 17 Open-market sale · S −1,100 $59.35 −$65.3K 25,000
Collins Helen Louise CHIEF MEDICAL OFFICER Aug 17 Open-market sale · S −3,900 $58.37 −$228K 26,100
Collins Helen Louise CHIEF MEDICAL OFFICER Aug 17 Exercise / conversion · M +5,000 $2.48 +$12.4K 30,000
Hohl Benjamin CHIEF FINANCIAL OFFICER Aug 17 Open-market sale · S −1,388 $59.35 −$82.4K 40,036

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support